Cargando…
Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?
Epidemiological studies suggest an increased prevalence of cardiovascular disease (CVD) in patients with psoriasis (PS). Therefore, emphasis has lately been laid on the necessity for clinical evaluation of the risk of CVD in these patients. The systemic inflammatory markers C-reactive protein (CRP)...
Autores principales: | Kaur, Sirje, Kingo, Külli, Zilmer, Mihkel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602647/ https://www.ncbi.nlm.nih.gov/pubmed/28947858 http://dx.doi.org/10.1155/2017/7279818 |
Ejemplares similares
-
Metabolomic Differences between the Skin and Blood Sera of Atopic Dermatitis and Psoriasis
por: Ilves, Liis, et al.
Publicado: (2022) -
Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skin
por: Pohla, Liis, et al.
Publicado: (2020) -
Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
por: Ilves, Liis, et al.
Publicado: (2023) -
Metabolomic Analysis of Skin Biopsies from Patients with Atopic Dermatitis Reveals Hallmarks of Inflammation, Disrupted Barrier Function and Oxidative Stress
por: ILVES, Liis, et al.
Publicado: (2021) -
Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN
por: Keermann, Maris, et al.
Publicado: (2015)